|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
4
|
|
pubmed:dateCreated |
1995-12-12
|
|
pubmed:abstractText |
Thalassemia patients with heavy iron overload risk further increase of body iron stores after bone marrow transplantation (BMT) due to intensive red-cell transfusions in the post BMT course and to massive mobilization of iron deposits from marrow cells following the conditioning regimen. Nevertheless, iron chelation has not yet been used during the transplant period, mainly for concerns related to the toxicity and antiproliferative properties of the drug.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:issn |
0390-6078
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
80
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
300-4
|
|
pubmed:dateRevised |
2010-3-24
|
|
pubmed:meshHeading |
pubmed-meshheading:7590497-Adolescent,
pubmed-meshheading:7590497-Blood Cell Count,
pubmed-meshheading:7590497-Bone Marrow Transplantation,
pubmed-meshheading:7590497-Catheterization, Central Venous,
pubmed-meshheading:7590497-Chelation Therapy,
pubmed-meshheading:7590497-Child,
pubmed-meshheading:7590497-Deferoxamine,
pubmed-meshheading:7590497-Erythrocyte Transfusion,
pubmed-meshheading:7590497-Female,
pubmed-meshheading:7590497-Graft Survival,
pubmed-meshheading:7590497-Hemosiderosis,
pubmed-meshheading:7590497-Humans,
pubmed-meshheading:7590497-Infusions, Intravenous,
pubmed-meshheading:7590497-Iron,
pubmed-meshheading:7590497-Liver,
pubmed-meshheading:7590497-Male,
pubmed-meshheading:7590497-Siderophores,
pubmed-meshheading:7590497-Treatment Outcome,
pubmed-meshheading:7590497-beta-Thalassemia
|
|
pubmed:articleTitle |
Intravenous chelation therapy during transplantation for thalassemia.
|
|
pubmed:affiliation |
Divisione Ematologica, Ospedale di Pesaro, Italy.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Comparative Study,
Controlled Clinical Trial,
Research Support, Non-U.S. Gov't
|
